Outset Medical has raised $4.3 million in a new round of mixed financing, according to an SEC filing posted this week.
The San Jose, Calif.-based company develops and produces the Tablo hemodialysis system, an all-in-1 dialysis machine designed to handle water purification and dialysate production and be used in a variety of different settings.
Money in the round came from a single investor, with the 1st sale recorded on June 30, according to the filing. Sales in the round included debt, options and securities from exercisable options.
Outset Medical has not yet stated how it plans to use funds raised in the round.
The funding comes hot on the heels of the company’s $76.5 million Series C round, which closed in May.